Seltene Erkrankungen als Unternehmensstrategie mit Potenzial
Gespeichert in:
Veröffentlicht in: | Biospektrum 2011-05, Vol.17 (3), p.358-359 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | ger |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 359 |
---|---|
container_issue | 3 |
container_start_page | 358 |
container_title | Biospektrum |
container_volume | 17 |
creator | Garthoff, Bernward |
description | |
doi_str_mv | 10.1007/s12268-011-0054-y |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2404296105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2404296105</sourcerecordid><originalsourceid>FETCH-LOGICAL-c113y-47cbfce2141fbbeca69be0384fc54eee5a513779f4fc8ce76fa1699ca30accaf3</originalsourceid><addsrcrecordid>eNp1kM1LxDAQxYMouKz7B3greK7OpGnTgBdZ1g9YUNA9hzRM1u5HuibdQ_3rzVLBk3MZePzeG-Yxdo1wiwDyLiLnVZ0DYg5Qinw4YxOsk1Jxoc7ZBJSQOdSVvGSzGDeQplDAlZiw-3fa9eQpW4RtMH579GvymdnFbOV7Cp4-9-Rj7IPpad1Stm_77K1Lju_W7K7YhUsozX73lK0eFx_z53z5-vQyf1jmFrEYciFt4yxxFOiahqypVENQ1MLZUhBRaUospFQuCbUlWTmDlVLWFGCsNa6Yspsx9xC6ryPFXm-6Y_DppOYCBFcVQpkoHCkbuhgDOX0I7d6EQSPoU0967EmnnvSpJz0kDx89MbHp9fCX_L_pBwG3bK8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2404296105</pqid></control><display><type>article</type><title>Seltene Erkrankungen als Unternehmensstrategie mit Potenzial</title><source>SpringerNature Journals</source><creator>Garthoff, Bernward</creator><creatorcontrib>Garthoff, Bernward</creatorcontrib><identifier>ISSN: 0947-0867</identifier><identifier>EISSN: 1868-6249</identifier><identifier>DOI: 10.1007/s12268-011-0054-y</identifier><language>ger</language><publisher>Heidelberg: Spektrum Akademischer Verlag</publisher><subject>Biochemistry ; Biomedical and Life Sciences ; Biotechnologie ; Human Genetics ; Life Sciences ; Microbiology ; Pharmacology/Toxicology</subject><ispartof>Biospektrum, 2011-05, Vol.17 (3), p.358-359</ispartof><rights>Springer-Verlag 2011</rights><rights>Springer-Verlag 2011.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12268-011-0054-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12268-011-0054-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids></links><search><creatorcontrib>Garthoff, Bernward</creatorcontrib><title>Seltene Erkrankungen als Unternehmensstrategie mit Potenzial</title><title>Biospektrum</title><addtitle>Biospektrum</addtitle><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biotechnologie</subject><subject>Human Genetics</subject><subject>Life Sciences</subject><subject>Microbiology</subject><subject>Pharmacology/Toxicology</subject><issn>0947-0867</issn><issn>1868-6249</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kM1LxDAQxYMouKz7B3greK7OpGnTgBdZ1g9YUNA9hzRM1u5HuibdQ_3rzVLBk3MZePzeG-Yxdo1wiwDyLiLnVZ0DYg5Qinw4YxOsk1Jxoc7ZBJSQOdSVvGSzGDeQplDAlZiw-3fa9eQpW4RtMH579GvymdnFbOV7Cp4-9-Rj7IPpad1Stm_77K1Lju_W7K7YhUsozX73lK0eFx_z53z5-vQyf1jmFrEYciFt4yxxFOiahqypVENQ1MLZUhBRaUospFQuCbUlWTmDlVLWFGCsNa6Yspsx9xC6ryPFXm-6Y_DppOYCBFcVQpkoHCkbuhgDOX0I7d6EQSPoU0967EmnnvSpJz0kDx89MbHp9fCX_L_pBwG3bK8</recordid><startdate>20110501</startdate><enddate>20110501</enddate><creator>Garthoff, Bernward</creator><general>Spektrum Akademischer Verlag</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20110501</creationdate><title>Seltene Erkrankungen als Unternehmensstrategie mit Potenzial</title><author>Garthoff, Bernward</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c113y-47cbfce2141fbbeca69be0384fc54eee5a513779f4fc8ce76fa1699ca30accaf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2011</creationdate><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biotechnologie</topic><topic>Human Genetics</topic><topic>Life Sciences</topic><topic>Microbiology</topic><topic>Pharmacology/Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Garthoff, Bernward</creatorcontrib><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Biospektrum</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garthoff, Bernward</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Seltene Erkrankungen als Unternehmensstrategie mit Potenzial</atitle><jtitle>Biospektrum</jtitle><stitle>Biospektrum</stitle><date>2011-05-01</date><risdate>2011</risdate><volume>17</volume><issue>3</issue><spage>358</spage><epage>359</epage><pages>358-359</pages><issn>0947-0867</issn><eissn>1868-6249</eissn><cop>Heidelberg</cop><pub>Spektrum Akademischer Verlag</pub><doi>10.1007/s12268-011-0054-y</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0947-0867 |
ispartof | Biospektrum, 2011-05, Vol.17 (3), p.358-359 |
issn | 0947-0867 1868-6249 |
language | ger |
recordid | cdi_proquest_journals_2404296105 |
source | SpringerNature Journals |
subjects | Biochemistry Biomedical and Life Sciences Biotechnologie Human Genetics Life Sciences Microbiology Pharmacology/Toxicology |
title | Seltene Erkrankungen als Unternehmensstrategie mit Potenzial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T11%3A01%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Seltene%20Erkrankungen%20als%20Unternehmensstrategie%20mit%20Potenzial&rft.jtitle=Biospektrum&rft.au=Garthoff,%20Bernward&rft.date=2011-05-01&rft.volume=17&rft.issue=3&rft.spage=358&rft.epage=359&rft.pages=358-359&rft.issn=0947-0867&rft.eissn=1868-6249&rft_id=info:doi/10.1007/s12268-011-0054-y&rft_dat=%3Cproquest_cross%3E2404296105%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2404296105&rft_id=info:pmid/&rfr_iscdi=true |